Northern Trust Corp Has $12.68 Million Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Northern Trust Corp boosted its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 18.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 966,347 shares of the company’s stock after acquiring an additional 147,522 shares during the quarter. Northern Trust Corp owned 1.13% of Pediatrix Medical Group worth $12,678,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Nomura Asset Management Co. Ltd. raised its stake in Pediatrix Medical Group by 95.3% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock worth $33,000 after acquiring an additional 1,220 shares in the last quarter. Parkside Financial Bank & Trust increased its stake in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after buying an additional 1,040 shares in the last quarter. AlphaQuest LLC increased its stake in shares of Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock valued at $66,000 after buying an additional 2,012 shares in the last quarter. Smartleaf Asset Management LLC increased its stake in shares of Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after buying an additional 6,090 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its stake in shares of Pediatrix Medical Group by 218.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company’s stock valued at $98,000 after buying an additional 5,104 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Price Performance

Shares of MD opened at $14.89 on Friday. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $17.67. The stock has a market cap of $1.28 billion, a P/E ratio of -12.41, a price-to-earnings-growth ratio of 1.74 and a beta of 1.26. The stock’s 50-day moving average price is $13.71 and its two-hundred day moving average price is $14.09.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $458.36 million for the quarter, compared to analysts’ expectations of $451.44 million. During the same quarter in the previous year, the business posted $0.20 EPS. Pediatrix Medical Group’s revenue for the quarter was down 7.4% on a year-over-year basis. On average, equities analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on MD. UBS Group lowered their target price on Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating for the company in a research note on Monday, May 12th. Macquarie lifted their price objective on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Thursday, May 8th. Truist Financial lowered their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 11th. Finally, StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $16.67.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.